KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description
GigaScience · 28.12.2022 · 12
DOI: 10.1093/gigascience/giad057 ↗Kurz gefasst
Fachartikel in der Zeitschrift GigaScience, online erschienen am 21.08.2023. Verfasst von Chunyu Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Huck Institutes of Life Sciences, Pennsylvania State University, State College, PA 16801, USA. Hauptthemen laut MEDLINE: Pattern Recognition, Automated, Drug Discovery. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Institutes of Health, National Science Foundation.
Abstract (Originalsprache)
Background
Computational drug repurposing is a cost- and time-efficient approach that aims to identify new therapeutic targets or diseases (indications) of existing drugs/compounds. It is especially critical for emerging and/or orphan diseases due to its cheaper investment and shorter research cycle compared with traditional wet-lab drug discovery approaches. However, the underlying mechanisms of action (MOAs) between repurposed drugs and their target diseases remain largely unknown, which is still a main obstacle for computational drug repurposing methods to be widely adopted in clinical settings.
Results
In this work, we propose KGML-xDTD: a Knowledge Graph–based Machine Learning framework for explainably predicting Drugs Treating Diseases. It is a 2-module framework that not only predicts the treatment probabilities between drugs/compounds and diseases but also biologically explains them via knowledge graph (KG) path-based, testable MOAs. We leverage knowledge-and-publication–based information to extract biologically meaningful “demonstration paths” as the intermediate guidance in the Graph-based Reinforcement Learning (GRL) path-finding process. Comprehensive experiments and case study analyses show that the proposed framework can achieve state-of-the-art performance in both predictions of drug repurposing and recapitulation of human-curated drug MOA paths.
Conclusions
KGML-xDTD is the first model framework that can offer KG path explanations for drug repurposing predictions by leveraging the combination of prediction outcomes and existing biological knowledge and publications. We believe it can effectively reduce “black-box” concerns and increase prediction confidence for drug repurposing based on predicted path-based explanations and further accelerate the process of drug discovery for emerging diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Huck Institutes of Life Sciences, Pennsylvania State University, State College, PA 16801, USA.
- Department of Computer Science, Northwestern University, Evanston, IL 60208, USA.
- Department of Computer Science and Engineering, Pennsylvania State University, State College, PA 16801, USA.
- Department of Biology, Pennsylvania State University, State College, PA 16801, USA.
ORCID-Profile: Chunyu Ma, Zhihan Zhou, David Koslicki
Förderung
- NCATS NIH HHS
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Ma, C., Zhou, Z., Liu, H., & Koslicki, D. (2022). KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description. GigaScience, 12. https://doi.org/10.1093/gigascience/giad057
Vancouver
Ma C, Zhou Z, Liu H, Koslicki D. KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description. GigaScience. 2022;12. doi:10.1093/gigascience/giad057
BibTeX
@article{Ma2022,
author = {Ma, Chunyu and Zhou, Zhihan and Liu, Han and Koslicki, David},
title = {KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description},
journal = {GigaScience},
year = {2022},
volume = {12},
doi = {10.1093/gigascience/giad057}
}
EUVIMED